MedTrace Logo

Prevalence of Glaucoma in Belgium: a Multicenter National Trial

NCT05703724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1418

Last updated 2023-05-31

No results posted yet for this study

Summary

To screen for the presence of glaucoma in a Belgian population over 40 years old using an AI algorithm developed for the detection of glaucoma based on fundus pictures.

Conditions

Interventions

DEVICE

AI algorithm for the detection of glaucoma

The investigational device that will be used during this study is an AI algorithm embedded into an API for the detection of glaucoma developed by MONA.health

Sponsors & Collaborators

  • Santen Oy

    collaborator INDUSTRY

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Ingeborg Stalmans, MD, PhD · Universitaire Ziekenhuizen KU Leuven

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-08
Primary Completion
2023-05-08
Completion
2023-05-08

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05703724 on ClinicalTrials.gov